What is it about?
Titanium dioxide nanoparticles was used as helpers to build new drug-like compounds in a simple, eco-friendly way. This method saves time, uses fewer chemicals, and creates less waste. They tested these compounds against hepatitis A virus. One compound (Sample 5) was especially strong, fighting 91% of the virus. This offers a greener, safer path to making antiviral medicines.
Featured Image
Why is it important?
Novelty lies in using TiO₂ nanoparticles as a reusable catalyst for a safe, eco-friendly three-component synthesis of new pyran-carbonitrile derivatives. This green approach saves time and reduces chemical waste. The standout finding is Sample 5, showing 91% antiviral activity against hepatitis A virus a rare and promising result. It combines sustainable chemistry with strong antiviral potential in one platform.
Perspectives
This research merges green chemistry with real medical potential. Using TiO₂ nanoparticles to simplify synthesis while cutting waste is a smart, sustainable step. Sample 5's 91% antiviral activity against hepatitis A is genuinely exciting, though I'd want to see toxicity and mechanism data before celebrating. Still, it's a promising, eco-conscious lead worth pursuing further.
Gehan El-Bassyouni
National Research Centre (NRC), Dokki, Cairo, 12622, Egypt
Read the Original
This page is a summary of: TiO2 nanoparticle as catalyst for an efficient green one-pot synthesis of 1H-3-Indolyl Derivatives as significant antiviral activity, Bioorganic Chemistry, July 2022, Elsevier,
DOI: 10.1016/j.bioorg.2022.105805.
You can read the full text:
Contributors
The following have contributed to this page
